Related Experiment Video
Updated: Apr 17, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Recurrent gain-of-function USP8 mutations in Cushing's disease
Zeng-Yi Ma1, Zhi-Jian Song2, Jian-Hua Chen3
1Department of Neurosurgery, Shanghai Pituitary Tumor Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
Somatic USP8 mutations are common in Cushing's disease, driving excess ACTH production. Targeting USP8 or EGFR offers a promising therapeutic strategy for these pituitary tumors.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Cushing's disease results from excess cortisol production, often due to ACTH-secreting pituitary adenomas.
- Genetic causes of ACTH-secreting pituitary adenomas remain largely unknown.
- Understanding the genetic landscape is crucial for targeted therapies.
Purpose of the Study:
- To identify genetic alterations in ACTH-secreting pituitary adenomas.
- To investigate the role of USP8 mutations in Cushing's disease pathogenesis.
- To explore potential therapeutic targets for USP8-mutated tumors.
Main Methods:
- Whole-exome sequencing of 12 ACTH-secreting pituitary adenomas and matched blood samples.
- Sanger and targeted sequencing of USP8 in 258 additional pituitary adenomas.
- Functional assays assessing USP8-EGFR interaction and ACTH secretion.
Main Results:
- Somatic USP8 mutations were identified exclusively in exon 14 of ACTH-secreting pituitary adenomas (62.04% in 108 cases).
- These mutations disrupt USP8 binding to 14-3-3 protein, increasing EGFR stability and POMC expression.
- USP8-mutated tumors showed smaller size but higher ACTH production compared to wild-type.
- USP8 knockdown or EGFR inhibition reduced ACTH secretion in vitro.
Conclusions:
- Somatic gain-of-function USP8 mutations are a frequent driver of ACTH overproduction in Cushing's disease.
- USP8 and EGFR represent potential therapeutic targets for corticotrophin adenomas.
- This study elucidates key genetic mechanisms and therapeutic avenues for Cushing's disease.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

